Association between albumin-to-globulin ratio and the risk of overall survival in advanced non-small cell lung cancer patients with anlotinib treatment: a retrospective cohort study

• Published in: BMC pulmonary medicine Vol. 23; no. 1; pp. 275 - 10
• Main Authors: Chen, Jinzhan, Xie, Congyi, Yang, Yimin, Yang, Shuwen, Huang, Jinxian, Ye, Feiyang, Lin, Zhenyang, Tong, Lin, Liu, Jiaxin
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 25.07.2023; BioMed Central; BMC
• Subjects: Albumin; Anlotinib; Cohort analysis; Critical care; Data analysis; Drug therapy; Globulin; Globulins; Growth factors; Immunotherapy; Kinases; Lung cancer; Lung cancer, Non-small cell; Medical prognosis; Metastasis; Non-small cell lung carcinoma; Normal distribution; Overall survival; Patient outcomes; Patients; Prognosis; Pulmonology; Regression analysis; Small cell lung carcinoma; Variables; China; Albumin; Anlotinib; Overall survival; Lung cancer; Globulin

Researches about the association between serum albumin-to-globulin ratio (AGR) and the prognosis of lung cancer are limited. We aimed to investigate the relationship between AGR and overall survival (OS) in patients with advanced non-small-cell lung cancer (NSCLC) treated with anlotinib. A retrospec...